The goal of this training program is to improve pharmacists’ ability to make informed decisions and support their patients regarding the management of medication needs of patients with diabetes. The online modules will include knowledge checks presented in an engaging format to facilitate participant learning.
At the completion of this application-based activity, participants will be able to:
- List pharmacotherapy options for patients with type 1 and 2 diabetes.
- Explain key characteristics of each class of medications for the treatment of diabetes.
- Discuss recently approved medications and expanded indications for existing therapies for the management of diabetes.
- Describe current overall glucose-lowering and injectable intensification strategies as published in current practice guidelines.
- Summarize key findings from recent cardiovascular (CV) outcomes trials used to demonstrate reduced CV and renal events and their impact on current treatment recommendations.
- Describe key self-care behaviors for the management of diabetes. Identify strategies to optimize patient care using the Pharmacist's Patient Care Process.
- State drug-specific factors to consider when selecting antihyperglycemic treatment in patients with type 1 and type 2 diabetes, including but not limited to dosing, combination products, and cost.
- State patient-specific factors to consider when selecting antihyperglycemic treatment in patients with type 1and type 2 diabetes, including but not limited to adherence predictability, age, ethnicity, and patient risk factors.
- Identify patient and drug specific factors to maximize adherence and improve achievement of treatment goals while performing medications reviews.
- Discuss strategies to optimize patient care using the Pharmacist's Patient Care Process.
Activity type: Application-based
Target Audience: Pharmacists
Learning Level: 2
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hour of CPE credit (0.2 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-20-245-H01-P.
To obtain credit for completing Navigating the Crowded Space of Diabetes Medications, participants will need to complete the 4 activities, complete the assessment with a grade of 70% or better, complete the evaluation questions, and then CLAIM credit. Participants need to have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.
Initial release date: August 31, 2020
Expiration date: August 31, 2023 - No credit can be earned after this date
Development and Support
Navigating the Crowded Space of Diabetes Medications is an activity developed by the American Pharmacists Association and supported by an educational grant from Novo Nordisk. ©2020 American Pharmacists Association
Jennifer Trujillo, PharmD, FCCP, BCPS, CDE, BC-ADM declares that she is a Consultant for Novo Nordisk and BD Pharmaceuticals.
Andrew Bzowyckyj, PharmD, BCPS, CDE, Kam L. Capoccia, PharmD, BCPS, CDCES, Joshua J.Neumiller, PharmD, CDE, FAADE, FASCP, APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at www.pharmacist.com/apha-disclosures.
Conflicts of interest have been resolved through content review by Helen Sairany, BA, PharmD, MBA, BCACP, Director of Content Development & Partnership at the American Pharmacists Association.
There is no fee associated with this activity.
Computer and internet access are required to complete this activity. Please visit our website to view the Technology System Requirements in order to have a positive learning experience.
|Activity Number||Credit Amount||Accreditation Period|
|ACPE# 0202-0000-20-245-H01-P||0.2 CEUs||August 31, 2020 - August 31, 2023|